Previous 10 | Next 10 |
2023-08-11 10:35:56 ET Cyanotech press release ( NASDAQ: CYAN ): Q1 GAAP EPS of -$0.22. Revenue of $5.14M (-23.5% Y/Y). For further details see: Cyanotech GAAP EPS of -$0.22, revenue of $5.14M
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2024, ended June 30, 2023. Commenting on the first quarter fiscal year 2024 re...
Cyanotech Corporation (Nasdaq Capital Market: CYAN), the world innovation leader in the cultivation and manufacture of microalgae for health and nutrition, including BioAstin® Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica® , today announces the appointment of Collette Kak...
2023-06-27 17:13:11 ET Cyanotech press release ( NASDAQ: CYAN ): FY GAAP EPS of -$0.55. Revenue of $23.18M (-35.6% Y/Y). Shares -3.67% AH. For further details see: Cyanotech GAAP EPS of -$0.55, revenue of $23.18M
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth quarter and fiscal year 2023, ended March 31, 2023. Commenting on the fiscal year results (changes s...
Cyanotech press release ( NASDAQ: CYAN ): Q3 GAAP EPS of -$0.10. Revenue of $5.59M (-40.9% Y/Y). For further details see: Cyanotech GAAP EPS of -$0.10, revenue of $5.59M
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and first nine months of fiscal year 2023, ended December 31, 2022. Commenting on the third q...
Summary A number of VBR "green energy" picks have popped higher in January, pulling investment returns for the group of past picks strongly higher. A performance review of 46 previous selections since late June is discussed. I continue to refine the search and formula ideas for iden...
Cyanotech press release ( NASDAQ: CYAN ): Q2 GAAP EPS of -$0.15. Revenue of $5.18M (-45.0% Y/Y). For further details see: Cyanotech GAAP EPS of -$0.15, revenue of $5.18M
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter and first six months of fiscal year 2023, ended September 30, 2022. Commenting on ...
News, Short Squeeze, Breakout and More Instantly...
Cyanotech Corporation Company Name:
CYAN Stock Symbol:
NASDAQ Market:
Cyanotech Corporation Website:
The new gummy offers an industry-leading 12mg of Hawaiian Astaxanthin ® per serving – 6000 times the antioxidant power of Vitamin C – with science-backed, multifunctional benefits and a 40-year legacy of farm-direct transparency and traceability. Nutrex-Hawaii...
The Dow Jones index closed lower by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern a...
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and first nine months of fiscal year 2024, ended December 31, 2023. Commenting on the third...